From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

Forbes contributors publish independent expert analyses and insights. Alison Escalante M.D. covers neurodiversity, pediatrics and parenting. Stimulant medications are considered the first-line ...

WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...

Using a causal analytic method to account for age and other time-varying characteristics, including household income, behavior problems, and parental support, there was no evidence showing that ...

Not long ago, most people thought of attention deficit hyperactivity disorder, or ADHD, as a childhood condition that would eventually be outgrown. Now it's everywhere. Subscribe to our newsletter for ...

For decades, ADHD stimulant medications have been thought to sharpen attention, but new research has uncovered something very different is at play. These drugs don't actually provide laser-sharp focus ...

From 2021 to 2023, stimulant marketing payments doubled and tripled for physicians and advanced practice clinicians, respectively. The increases were driven in large part by growth in marketing to ...

Mary Bushell does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Human fascination with stimulants is deeply rooted in our biology. Whether it’s the energizing buzz of caffeine, the focus sharpened by prescription medications like methylphenidate or amphetamines, ...